Friday, June 1, 2012

Vol. 18, No. 11

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 11  June 1, 2012
(The next issue will be on June 15, 2012)
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1dOqVon-A-nhszJWUvzfYon/

Abuhasna SD, Al Jundi AH, Tarifi HA (2012) Recombinant-activated factor VII in patients with ncontrolled bleeding: A retrospective observational analysis. Asian J Transfus Sci 6:14-18.
http://www.ncbi.nlm.nih.gov/pubmed/22623836

Ataga KI, Brittain JE, Desai P, May R, Jones S, Delaney J, . . . Key NS (2012) Association of coagulation activation with clinical complications in sickle cell disease. PLoS One 7:e29786.
http://www.ncbi.nlm.nih.gov/pubmed/22253781

Augoustides JG (2012) Breakthroughs in Anticoagulation: Advent of the Oral Direct Factor Xa Inhibitors. J Cardiothorac Vasc Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/22608466

Bind MA, Baccarelli A, Zanobetti A, Tarantini L, Suh H, Vokonas P, Schwartz J (2012) Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort. Epidemiology 23:332-340.
http://www.ncbi.nlm.nih.gov/pubmed/22237295

Biswas I, Garg I, Singh B, Khan GA (2012) A key role of toll-like receptor 3 in tissue factor activation through extracellular signal regulated kinase 1/2 pathway in a murine hypoxia model. Blood Cells Mol Dis.
http://www.ncbi.nlm.nih.gov/pubmed/22647506

Boles JC, Williams JC, Hollingsworth RM, Wang JG, Glover SL, Owens AP, 3rd, . . . Mackman N (2012) Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. Thromb Res 129:197-203.
http://www.ncbi.nlm.nih.gov/pubmed/21762960

Broze GJ, Jr., Girard TJ (2012) Tissue factor pathway inhibitor: structure-function. Front Biosci 17:262-280.
http://www.ncbi.nlm.nih.gov/pubmed/22201743

Callum JL, Rizoli S (2012) Plasma transfusion for patients with severe hemorrhage: what is the evidence? Transfusion 52 Suppl 1:30S-37S.
http://www.ncbi.nlm.nih.gov/pubmed/22578369

Cervera A, Amaro S, Chamorro A (2012) Oral anticoagulant-associated intracerebral hemorrhage. J Neurol 259:212-224.
http://www.ncbi.nlm.nih.gov/pubmed/21748282

Chen X, Li Z, Zhang J, Mao Z, Ma D, Wang H (2012) Tissue factor pathway inhibitor-2 may interact with nuclear protein RASSF1C. Acta Biochim Biophys Sin (Shanghai) 44:183-185.
http://www.ncbi.nlm.nih.gov/pubmed/22232300

Eggers KM, Kempf T, Lind L, Sundstrom J, Wallentin L, Wollert KC, Siegbahn A (2012) Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects. Scand J Clin Lab Invest 72:45-51.
http://www.ncbi.nlm.nih.gov/pubmed/22023041

Ekser B, Lin CC, Long C, Echeverri GJ, Hara H, Ezzelarab M, . . . Gridelli B (2012) Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation. Transpl Int.
http://www.ncbi.nlm.nih.gov/pubmed/22642260

Garcia-Matte R, Maria Constanza Beltran M, Ximena Fonseca A, Pamela Zuniga C (2012) Management of children with inherited mild bleeding disorders undergoing adenotonsillar procedures. Int J Pediatr Otorhinolaryngol 76:291-294.
http://www.ncbi.nlm.nih.gov/pubmed/22188821

Giansily-Blaizot M, Lopez E, Viart V, Chafa O, Tapon-Bretaudiere J, Claustres M, Taulan M (2012) Lethal factor VII deficiency due to novel mutations in the F7 promoter: Functional analysis reveals disruption of HNF4 binding site. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22628013

Gil-Bernabe AM, Ferjancic S, Tlalka M, Zhao L, Allen PD, Im JH, . . . Muschel RJ (2012) Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119:3164-3175.
http://www.ncbi.nlm.nih.gov/pubmed/22327225

Gorczyca ME, Nair SC, Jilma B, Priya S, Male C, Reitter S, . . . Srivastava A (2012) Inhibition of tissue factor pathway inhibitor (TFPI) by the aptamer BAX499 improves clotting of hemophiliac blood and plasma. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22632032

Hahn N, Heiden M, Seitz R, Salge-Bartels U (2012) Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion. J Cancer Res Clin Oncol 138:695-703.
http://www.ncbi.nlm.nih.gov/pubmed/22237453

Hajj-Chahine J (2012) eComment. Activated recombinant factor VII in intractable bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 14:698.
http://www.ncbi.nlm.nih.gov/pubmed/22589339

Hall AB, Carson BC (2012) Reversal of warfarin-induced coagulopathy: review of treatment options. J Emerg Nurs 38:98-101.
http://www.ncbi.nlm.nih.gov/pubmed/21474171

Hoffman M, Dargaud Y (2012) Mechanisms and monitoring of bypassing agent therapy. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22632160

Hot A, Lenief V, Miossec P (2012) Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis 71:768-776.
http://www.ncbi.nlm.nih.gov/pubmed/22258491

Hoving S, Heeneman S, Gijbels MJ, te Poele JA, Pol JF, Gabriels K, . . . Stewart FA (2011) Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice. Radiother Oncol 101:100-108.
http://www.ncbi.nlm.nih.gov/pubmed/22001104

Huang C, Yang YF, Yin N, Chen JL, Wang J, Zhang H, Tan ZP (2012) Congenital heart defect and mental retardation in a patient with a 13q33.1-34 deletion. Gene 498:308-310.
http://www.ncbi.nlm.nih.gov/pubmed/22366306

Jiang MH, Wang ZY, Yu ZQ, Bai X, Cao LJ, Su J, . . . Ruan CG (2011) [Genotype and phenotype analysis of congenital coagulator factor VII deficiency in four Chinese pedigrees]. Zhonghua Xue Ye Xue Za Zhi 32:147-152.
http://www.ncbi.nlm.nih.gov/pubmed/21535950

Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR (2012) Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity. Crit Care Med 40:1844-1850.
http://www.ncbi.nlm.nih.gov/pubmed/22610188

Kaufner L, Schuster M, Vogt M, Kroncke TJ, von Heymann C (2012) [Case Report: Recurrent postpartum haemorrhage after emergency caesarean section - Clipping, embolization and haemostaseological therapy]. Anasthesiol Intensivmed Notfallmed Schmerzther 47:308-314.
http://www.ncbi.nlm.nih.gov/pubmed/22628026

Langstrom S, Peltola V, Petaja J, Ruuskanen O, Heikinheimo M (2012) Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia. Acta Paediatr.
http://www.ncbi.nlm.nih.gov/pubmed/22646857

Le Sache F, Le Bonniec B, Gaussem P, Dizier B, Tagzirt M, Godier A, . . . Samama CM (2012) Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit. Br J Anaesth 108:586-593.
http://www.ncbi.nlm.nih.gov/pubmed/22258204

Lee CN, Heidbrink JL, McKinnon K, Bushman V, Olsen H, FitzHugh W, . . . Moore PA (2012) RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival. Pancreas 41:84-94.
http://www.ncbi.nlm.nih.gov/pubmed/21934552

Lin Y, Moltzan CJ, Anderson DR (2012) The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework. Transfus Med.
http://www.ncbi.nlm.nih.gov/pubmed/22630348

Liu S, Sammons V, Fairhall J, Reddy R, Tu J, Hong Duong TT, Stoodley M (2012) Molecular responses of brain endothelial cells to radiation in a mouse model. J Clin Neurosci.
http://www.ncbi.nlm.nih.gov/pubmed/22595350

Maroney SA, Ellery PE, Wood JP, Ferrel JP, Bonesho CE, Mast AE (2012) Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor. Biochem J 443:259-266.
http://www.ncbi.nlm.nih.gov/pubmed/22239091

McDowell SA, Ma Y, Kusano R, Akinbi HT (2011) Simvastatin is protective during Staphylococcus aureus pneumonia. Curr Pharm Biotechnol 12:1455-1462.
http://www.ncbi.nlm.nih.gov/pubmed/21401521

McQuilten ZK, Barnes C, Zatta A, Phillips LE (2012) Off-Label Use of Recombinant Factor VIIa in Pediatric Patients. Pediatrics.
http://www.ncbi.nlm.nih.gov/pubmed/22641758

Mokhtar GM, Tantawy AA, Adly AA, Telbany MA, Arab SE, Ismail M (2012) A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/22610136

Oehmcke S, Morgelin M, Malmstrom J, Linder A, Chew M, Thorlacius H, Herwald H (2012) Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. Cell Microbiol 14:107-119.
http://www.ncbi.nlm.nih.gov/pubmed/21951918

Ogasawara S, Stokol T (2012) Interleukin-10 inhibits lipopolysaccharide-induced upregulation of tissue factor in canine peripheral blood monocytes. Vet Immunol Immunopathol.
http://www.ncbi.nlm.nih.gov/pubmed/22609246

Peraramelli S, Suylen DP, Rosing J, Hackeng TM (2012) The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22627666

Qin Y, Zhang S, Gong W, Li J, Jia J, Quan Z (2012) Adenovirus-mediated gene transfer of tissue factor pathway inhibitor-2 inhibits gallbladder carcinoma growth in vitro and in vivo. Cancer Sci 103:723-730.
http://www.ncbi.nlm.nih.gov/pubmed/22320835

Rank A, Liebhardt S, Zwirner J, Burges A, Nieuwland R, Toth B (2012) Circulating microparticles in patients with benign and malignant ovarian tumors. Anticancer Res 32:2009-2014.
http://www.ncbi.nlm.nih.gov/pubmed/22593480

Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, . . . Lynch J (2012) Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke 43:952-957.
http://www.ncbi.nlm.nih.gov/pubmed/22363056

Saeed D, Albert A, Kamiya H, Maxhera B, Westenfeld R, Lichtenberg A (2012) Five Days of No Anticoagulation or Antiplatelet Therapy and NovoSeven Administration in a HeartWare HVAD Patient. Artif Organs.
http://www.ncbi.nlm.nih.gov/pubmed/22607278

Savitskaya TV, Kisialeu LP, Lipay NV (2012) The mRNA expression of various angiogenesis-related genes in pediatric sarcomas and nonmalignant lesions of tissue. Pediatr Hematol Oncol 29:28-37.
http://www.ncbi.nlm.nih.gov/pubmed/22304008

Sebag SC, Bastarache JA, Ware LB (2011) Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome. Curr Pharm Biotechnol 12:1481-1496.
http://www.ncbi.nlm.nih.gov/pubmed/21401517

Singh A, Foster GD, Gunawardana J, McCoy TA, Nguyen T, Vander Veur S, . . . Koneti Rao A (2012) Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/22612792

Smith JE (2012) The use of recombinant activated factor VII (rFVIIa) in the management of patients with major haemorrhage in military hospitals over the last 5 years. Emerg Med J.
http://www.ncbi.nlm.nih.gov/pubmed/22609697

Smith JE, Fawcett R, Randalls B (2012) The use of recombinant activated factor VII in a patient with penetrating chest trauma and ongoing pulmonary hemorrhage. Mil Med 177:614-616.
http://www.ncbi.nlm.nih.gov/pubmed/22645892

Smith SA, McMichael MA, Gilor S, Galligan AJ, Hoh CM (2012) Correlation of hematocrit, platelet concentration, and plasma coagulation factors with results of thromboelastometry in canine whole blood samples. Am J Vet Res 73:789-798.
http://www.ncbi.nlm.nih.gov/pubmed/22620692

Stepien E, Kablak-Ziembicka A, Czyz J, Przewlocki T, Malecki M (2012) Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging. Expert Opin Ther Targets.
http://www.ncbi.nlm.nih.gov/pubmed/22616736

Su LL, Chong YS (2012) Massive obstetric haemorrhage with disseminated intravascular coagulopathy. Best Pract Res Clin Obstet Gynaecol 26:77-90.
http://www.ncbi.nlm.nih.gov/pubmed/22101177

Sun Q, Chen L, Gao M, Jiang W, Shao F, Li J, . . . Yu B (2012) Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-kappaB. Int Immunopharmacol 12:88-93.
http://www.ncbi.nlm.nih.gov/pubmed/22079591

Valera MC, Kemoun P, Cousty S, Sie P, Payrastre B (2012) Inherited platelet disorders and oral health. J Oral Pathol Med.
http://www.ncbi.nlm.nih.gov/pubmed/22583386

Wang MS, Jin YH, Zheng FX, Xie HX, Xu PF, Niu ZZ (2011) [Gene analysis of a combined inherited factor VII and factor X deficiency pedigree]. Zhonghua Xue Ye Xue Za Zhi 32:854-857.
http://www.ncbi.nlm.nih.gov/pubmed/22339961

Wu Z, Liu MC, Liang M, Fu J (2012) Sirt1 protects against thrombomodulin down-regulation and lung coagulation after particulate matter exposure. Blood 119:2422-2429.
http://www.ncbi.nlm.nih.gov/pubmed/22262770

Xing ZF, Wang XF, Dai J, Lu YL, Xu GQ, Xi XD, Wang HL (2011) [Two novel mutations in one pedigree with hereditary Factor VII deficiency]. Zhonghua Xue Ye Xue Za Zhi 32:158-162.
http://www.ncbi.nlm.nih.gov/pubmed/21535952

Yapijakis C, Bramos A, Nixon AM, Ragos V, Vairaktaris E (2012) The Interplay between Hemostasis and Malignancy: The Oral Cancer Paradigm. Anticancer Res 32:1791-1800.
http://www.ncbi.nlm.nih.gov/pubmed/22593463

Young G, Cooper DL, Gut RZ (2012) Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008). Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22631073

__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.


DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________